Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Get Free Report) saw a large decline in short interest in July. As of July 15th, there was short interest totaling 19,796 shares, a decline of 40.4% from the June 30th total of 33,197 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily volume of 68,010 shares, the short-interest ratio is currently 0.3 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings downgraded shares of Baird Medical Investment from a “sell (d)” rating to a “sell (d-)” rating in a report on Friday, May 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.
View Our Latest Stock Report on Baird Medical Investment
Institutional Inflows and Outflows
Baird Medical Investment Price Performance
Baird Medical Investment stock traded up $0.01 during trading on Friday, reaching $1.04. The company had a trading volume of 37,966 shares, compared to its average volume of 973,944. The stock’s 50 day moving average price is $1.20 and its two-hundred day moving average price is $1.53. Baird Medical Investment has a 12-month low of $0.76 and a 12-month high of $3.75.
Baird Medical Investment Company Profile
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Featured Stories
- Five stocks we like better than Baird Medical Investment
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
- Peeling Out or Breaking Down? Ford’s High-Stakes Turnaround
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
